The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $26.38

Today's change+0.20 +0.76%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $26.38

Today's change+0.20 +0.76%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.

Boston Scientific Corp Hits New 52-week High

Boston Scientific Corp closed up Friday by (U.S.)$0.20 or 0.76% to (U.S.)$26.38 and setting a new 52-week high. Over the last five days, shares have gained 6.11% and 21.96% year to date. Shares have outperformed the S&P 500 by 5.99% during the last year.

Key company metrics

  • Open(U.S.) $25.97
  • Previous close(U.S.) $26.18
  • High(U.S.) $26.47
  • Low(U.S.) $25.97
  • Bid / Ask-- / --
  • YTD % change+21.96%
  • Volume9,033,424
  • Average volume (10-day)7,792,336
  • Average volume (1-month)7,021,033
  • Average volume (3-month)7,908,363
  • 52-week range(U.S.) $19.67 to (U.S.) $26.47
  • Beta1.11
  • Trailing P/E84.21×
  • P/E 1 year forward21.14×
  • Forward PEG1.74×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.31
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.51%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2,1912,1052,1261,964
Total other revenue--------
Total revenue2,1912,1052,1261,964
Gross profit1,5861,5191,4941,396
Total cost of revenue605586632568
Total operating expense2,0511,7572,4601,671
Selling / general / administrative828768774711
Research & development256232222210
Depreciation / amortization137136135136
Interest expense (income), net operating--------
Unusual expense (income)2051567727
Other operating expenses, total20202019
Operating income140348-334293
Interest income (expense), net non-operating-58-58-59-59
Gain (loss) on sale of assets--------
Other--------
Income before tax89257-397228
Income after tax124228-207202
Income tax, total-3529-19026
Net income124228-207202
Total adjustments to net income--------
Net income before extra. items124228-207202
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items124228-207202
Inc. avail. to common incl. extra. items124228-207202
Diluted net income124228-207202
Dilution adjustment--------
Diluted weighted average shares1,3841,3611,3571,370
Diluted EPS excluding extraordinary itemsvalue per share0.090.17-0.150.15
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.190.180.170.16